4.4 Article

Patient outcomes and tumor control in single-fraction versus hypofractionated stereotactic body radiation therapy for spinal metastases

期刊

JOURNAL OF NEUROSURGERY-SPINE
卷 34, 期 2, 页码 293-302

出版社

AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/2020.6.SPINE20349

关键词

stereotactic body radiation therapy; hypofraction; spine metastasis; pain; tumor control; oncology

资金

  1. NIH [5R01NS100866-02, 1R21CA226483-01]
  2. American Cancer Society [RGS-19-030-01]
  3. Eshelman Foundation
  4. Ian's Friends Foundation
  5. Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program
  6. Burroughs Wellcome Fund
  7. North Carolina Spine Society
  8. NIH/NINDS K12 NRCDP Physician Scientist Award

向作者/读者索取更多资源

Patients with spinal metastases who received hypofractionated SBRT more frequently achieved significant pain relief and an increased frequency of improvement in Karnofsky Performance Scale (KPS) compared with those treated with single-fraction SBRT. Local tumor control was similar in both groups, indicating the need for further research to understand the relationship between fractionation schedule and clinical outcomes.
OBJECTIVE Stereotactic body radiation therapy (SBRT) offers efficient, noninvasive treatment of spinal neoplasms. Single-fraction (SF) high-dose SBRT has a relatively narrow therapeutic window, while hypofractionated delivery of SBRT may have an improved safety profile with similar efficacy. Because the optimal approach of delivery is unknown, the authors examined whether hypofractionated SBRT improves pain and/or functional outcomes and results in better tumor control compared with SF-SBRT. METHODS This is a single-institution retrospective study of adult patients with spinal metastases treated with SF- or three-fraction (3F) SBRT from 2008 to 2019. Demographics and baseline characteristics, radiographic data, and post-treatment outcomes at a minimum follow-up of 3 months are reported. RESULTS Of the 156 patients included in the study, 70 (44.9%) underwent SF- SBRT (median total dose 1700 cGy) and 86 (55.1%) underwent 3F-SBRT (median total dose 2100 cGy). At baseline, a higher proportion of patients in the 3F-SBRT group had a worse baseline profile, including severity of pain (p < 0.05), average use of pain medication (p < 0.001), and functional scores (p < 0.05) compared with the SF-SBRT cohort. At the 3-month follow-up, the 3F-SBRT cohort experienced a greater frequency of improvement in pain compared with the SF- SBRT group (p < 0.05). Furthermore, patients treated with 3F-SBRT demonstrated a higher frequency of improved Karnofsky Performance Scale (KPS) scores (p < 0.05) compared with those treated with SF-SBRT, with no significant difference in the frequency of improvement in modified Rankin Scale scores. Local tumor control did not differ significantly between the two cohorts. CONCLUSIONS Patients who received spinal 3F-SBRT more frequently achieved significant pain relief and an increased frequency of improvement in KPS compared with those treated with SF-SBRT. Local tumor control was similar in the two groups. Future work is needed to establish the relationship between fractionation schedule and clinical outcomes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据